The transformation of radiation oncology using real-time magnetic resonance guidance: A review
William A. Hall(Medical College of Wisconsin), Christopher J. Schultz(Medical College of Wisconsin), David A. Jaffray(The University of Texas MD Anderson Cancer Center), Arjun Sahgal(Sunnybrook Health Science Centre), Robbert J.H.A. Tersteeg(University Medical Center Utrecht), Bradley A. Erickson(Medical College of Wisconsin), Laura A. Dawson(Princess Margaret Cancer Centre), X. Allen Li(Beijing Jiaotong University), Ananya Choudhury(University of Manchester), Marcel Verheij(Radboud University Nijmegen), Clifton D. Fuller(The University of Texas MD Anderson Cancer Center), E.S. Paulson(Medical College of Wisconsin), Kevin J. Harrington(Royal Marsden NHS Foundation Trust), M. Bassetti(University of Wisconsin–Madison), Clifford G. Robinson(Barnes-Jewish Hospital), Bruce D. Minsky(The University of Texas MD Anderson Cancer Center), Bas W. Raaymakers(University Medical Center Utrecht), Parag J. Parikh(Henry Ford Hospital), Uulke A. van der Heide(Radboud University Nijmegen), J J W Lagendijk(University Medical Center Utrecht), Percy Lee(University of California, Los Angeles)
Cited by 182
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2004|3.2k
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
|The Lancet|2018|1.7k
Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy—3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology
|Radiotherapy and Oncology|2006|1.6k
Genome-wide cell-free DNA fragmentation in patients with cancer
|Nature|2019|1.5k